Original ResearchPulsed electromagnetic field ameliorates cartilage degeneration by inhibiting mitogen-activated protein kinases in a rat model of osteoarthritis
Introduction
Osteoarthritis (OA) is a degenerative joint disease, characterized by progressive loss of articular cartilage, synovial inflammation, subchondral bone lesions, and osteophyte formation (A. Adatia, Rainsford, & Kean, 2012; P. Suri, Morgenroth, & Hunter, 2012; P. M. van der Kraan, 2012). Osteoarthritis is a leading cause of disability in the elderly (David T Felson, 2006) and is a major public health problem. The aging of the Chinese population will significantly increase the occurrence of osteoarthritis-related disability and socio-economic burden. Though there is a need in the literature for high-quality studies to support an increased relationship between sports and osteoarthritis (S. A. Richmond et al., 2013; G. Tran et al., 2016). Exposure to team sports, including soccer was shown to be a risk factor for osteoarthritis (J. A. Kettunen, Kujala, Kaprio, Koskenvuo, & Sarna, 2001; K. B. Klunder, Rud, & Hansen, 1980). High exposure to sport activity increases the odds of hip osteoarthritis compared to low exposure (E. Vingard, Alfredsson, Goldie, & Hogstedt, 1993). Exposure to gymnastics was found to be an increased risk of knee osteoarthritis in Hong Kong Chinese (E. C. Lau et al., 2000). Anterior cruciate ligament transection induced knee joint damage resembles cartilage degeneration observed in post-traumatic osteoarthritis (S. Kamekura et al., 2005). Treatment options for osteoarthritis include analgesics and anti-inflammatory drugs, glucosamine, physical exercises, and, surgical intervention as a last resort (Kim L Bennell, Hunter, & Hinman, 2012). Noninvasive therapeutic modalities such as physiotherapy including pulsed electromagnetic field (PEMF) have shown positive effects on osteoarthritis. Although a systematic review suggested that pulsed electromagnetic field treatment offers no clinical benefit in reducing the pain of knee osteoarthritis (C. J. McCarthy, Callaghan, & Oldham, 2006), there is indeed evidence that pulsed electromagnetic field provides meaningful benefits in these patients with respect to pain, stiffness, and disability (G. L. Bagnato, Miceli, Marino, Sciortino, & Bagnato, 2016; A. Gobbi, Lad, Petrera, & Karnatzikos, 2014; T. Iannitti, Fistetto, Esposito, Rottigni, & Palmieri, 2013; F. R. Nelson, Zvirbulis, & Pilla, 2013; P. Nicolakis et al., 2002; S. T. Sutbeyaz, Sezer, & Koseoglu, 2006; G. Thamsborg et al., 2005; H. Wuschech, von Hehn, Mikus, & Funk, 2015). In a clinical study, PEMF therapy reduced the total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) global scores in osteoarthritis patients (H. Wuschech, von Hehn, Mikus & Funk, 2015). Another study documented significant improvement in symptoms, knee function, and activity at 1-year follow-up. Although the results appeared to have deteriorated at 2 years, outcomes were still superior to pretreatment levels (A. Gobbi et al., 2014). In vivo studies have shown that pulsed electromagnetic field preserves the morphology of articular cartilage and slows the progression of osteoarthritis lesions in the knee of aged osteoarthritic guinea pigs (M. Fini et al., 2005), protects cartilage by inhibiting serum tumor necrosis factor-α(TNF-α) levels in anterior cruciate ligament transection (ACLT) rabbits (H. Guo et al., 2011), prevents ovariectomy-induced cartilage degeneration through up-regulation of X-linked inhibitor of apoptosis protein mRNA expression and down-regulation of Bax mRNA expression in rats (S. Li et al., 2011), and inhibit chondrocyte apoptosis and downregulate metalloproteinase-13 expression of knee joint cartilage in ovariectomized rats (Q. Luo et al., 2009). Our previous study also demonstrated the therapeutic effect of pulsed electromagnetic field on experimental osteoarthritis mediated via inhibition of apoptosis in chondrocytes (W. Xie, Zhou, Luo, Liu, & He, 2014). In an in vitro study, PEMF promoted chondrogenic differentiation of rat bone marrow-derived mesenchymal stem cells (rBMSCs) (F. Qiu et al., 2012). However, the underlying mechanisms by which PEMF inhibits cartilage degeneration are not fully understood.
Mitogen-activated protein kinases (MAPKs) play an important role in regulating cell growth, proliferation, differentiation, and apoptosis (K. K. Brown et al., 2008; Surena Namdari, Wei, Moore, & Chen, 2008, Indira Prasadam et al., 2010). MAPKs such as, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (c-Jun), and p38, play important roles in cartilage degenerative processes. The involvement of mitogen-activated protein kinases in the chondrogenic differentiation and cartilage formation and maturation has been demonstrated (Brent E Bobick & Kulyk, 2008). Mitogen-activated protein kinases have been demonstrated to be involved in murine collagen-induced arthritis (M. A. Rosillo et al., 2015). Moreover, inhibitors of mitogen-activated protein kinases have been shown to protect against articular cartilage erosion (Christelle Boileau et al., 2006, I. A. Schepetkin et al., 2015; Z-H Wen et al., 2010). Matrix metalloproteinases (MMPs) include a family of zinc-dependent enzymes that degrade extracellular matrix components. Cartilage degradation is associated with elevated expression of MMPs (A. Knapinska & Fields, 2012). In addition, mitogen-activated protein kinases signaling plays an important role in the matrix metalloproteinases-derived catabolic response of chondrocytes (Mohammed El Mabrouk, Sylvester & Zafarullah, 2007, Abdelhamid Liacini et al., 2003, B-C Sondergaard et al., 2010; SW Yoon, Chun, Sung, Kim, & Poo, 2008). The objective of the present study was to investigate the effects of pulsed electromagnetic field on urinary C-terminal cross-linking telopeptide of type II collagen (CTX-II), and cartilage morphology in ACLT-induced osteoarthritis rats. Further, we examined the effects of pulsed electromagnetic field on the expression of mitogen-activated protein kinases and metalloproteinases.
Section snippets
Study design and surgical technique for induction of osteoarthritis
All surgical and therapeutic procedures were approved by the ethics committee at the First Affiliated Hospital of University of South China and performed in accordance with national guidelines (The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30) equivalent to those of the National Institutes of Health “Guide for the Care and Use of Laboratory Animals”. Three-month old male Sprague–Dawley rats
Body weight and urinary C-terminal cross-linking telopeptide of type II collagen
There were no significant between-group differences with respect to body weight throughout the experiment (P > 0.05). There was no significant difference in urinary C-terminal cross-linking telopeptide of type II collagen (CTX-II) between the three groups at baseline (P > 0.05); however a significant increase in urinary CTX-II was observed in the ACLT group compared to the Sham group at post-operative weeks 1, 5, 9, and 13 (all P < 0.01). Of note, a significant decrease (−24.5%, −28.6%,
Discussion
Pulsed electromagnetic field (PEMF), an alternative noninvasive physiotherapeutic modality, is a promising alternative to drug-based therapies in the treatment of osteoarthritis (G. L. Bagnato et al., 2016, A. Gobbi et al., 2014, T. Iannitti et al., 2013, F. R. Nelson et al., 2013, P. Nicolakis et al., 2002, S. T. Sutbeyaz et al., 2006, G. Thamsborg et al., 2005, H. Wuschech et al., 2015). However, the mechanisms underlying the protective effect of PEMF on cartilage is not fully understood. In
Conflict of interest
None declared.
Funding
The study was supported by State Administration of Traditional Chinese Medicine of Hunan Province (2013112), Health Department of Hunan Province (B2014-052), and Natural Science Fund of Hunan Province (2015JJ3106), China.
Ethics approval
This study was approved by the ethics committee at the First Affiliated Hospital of University of South China.
Acknowledgements
We thank Medjaden Bioscience for assisting in language editing of this manuscript.
References (57)
- et al.
Osteoarthritis year in review 2015: Soluble biomarkers and the biped criteria
Osteoarthritis and Cartilage
(2016) - et al.
Signaling pathways implicated in oncostatin m-induced Aggrecanase-1 and matrix Metalloproteinase-13 expression in human articular chondrocytes
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research
(2007) - et al.
Pulsed electromagnetic fields reduce knee osteoarthritic lesion progression in the aged dunkin hartley Guinea pig
Journal of Orthopaedic Research
(2005) - et al.
Comparing different physical factors on serum Tnf-alpha levels, chondrocyte apoptosis, caspase-3 and caspase-8 expression in osteoarthritis of the knee in rabbits
Joint Bone Spine
(2011) - et al.
Osteoarthritis development in novel experimental mouse models induced by knee joint instability
Osteoarthritis and Cartilage
(2005) Osteoarthritis year 2012 in review: Biology
Osteoarthritis and Cartilage
(2012)- et al.
Induction of matrix metalloproteinase-13 gene expression by Tnf-Α is mediated by map kinases, Ap-1, and Nf-Κb transcription factors in articular chondrocytes
Experimental Cell Research
(2003) - et al.
Mapks are essential upstream signaling pathways in proteolytic cartilage degradation–divergence in pathways leading to aggrecanase and mmp-mediated articular cartilage degradation
Osteoarthritis and Cartilage
(2010) - et al.
Epidemiology of osteoarthritis and associated comorbidities
PM & R
(2012) - et al.
Treatment of knee osteoarthritis with pulsed electromagnetic fields: A randomized, double-blind, placebo-controlled study
Osteoarthritis and Cartilage
(2005)
Glucosamine sulfate reduces experimental osteoarthritis and nociception in rats: Association with changes of mitogen-activated protein kinase in chondrocytes
Osteoarthritis and Cartilage
Α-msh inhibits Tnf-Α-induced matrix Metalloproteinase-13 expression by modulating P38 kinase and nuclear factor Κb signaling in human chondrosarcoma Htb-94 cells
Osteoarthritis and Cartilage
Osteoarthritis of the knee and hip. Part I: Aetiology and pathogenesis as a basis for pharmacotherapy
The Journal of Pharmacy and Pharmacology
Pulsed electromagnetic fields in knee osteoarthritis: A double blind, placebo-controlled, randomized clinical Trial
Rheumatology (Oxford)
Regulation and role of Tgfbeta signaling pathway in aging and osteoarthritis joints
Aging and Disease
Management of osteoarthritis of the knee
BMJ
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage
Journal of Clinical Investigation
Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by Interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase
Arthritis & Rheumatism
Regulation of cartilage formation and maturation by mitogen-activated protein kinase signaling
Birth Defects Research Part C: Embryo Today: Reviews
Pd-0200347, an Α2δ ligand of the voltage gated calcium channel, inhibits in vivo activation of the Erk1/2 pathway in osteoarthritic chondrocytes: A pkcα dependent effect
Annals of the Rheumatic Diseases
P38 map kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis
Journal of Inflammation (London)
Osteoarthritis of the knee
New England Journal of Medicine
Symptomatic early osteoarthritis of the knee treated with pulsed electromagnetic fields: Two-year follow-up
Cartilage
Collagenase 1 and collagenase 3 expression in a Guinea pig model of osteoarthritis
Arthritis & Rheumatism
Pulsed electromagnetic field therapy for management of osteoarthritis-related pain, stiffness and physical function: Clinical experience in the elderly
Clinical Interventions in Aging
Schisandrae fructus inhibits Il-1beta-induced matrix metalloproteinases and inflammatory mediators production in Sw1353 human chondrocytes by suppressing Nf-kappab and mapk activation
Drug Development Research
Lower-limb function among former elite male athletes
The American Journal of Sports Medicine
Osteoarthritis of the hip and knee joint in retired football players
Acta orthopaedica Scandinavica
Cited by (15)
Promising application of pulsed electromagnetic fields on tissue repair and regeneration
2024, Progress in Biophysics and Molecular BiologyPromising application of Pulsed Electromagnetic Fields (PEMFs) in musculoskeletal disorders
2020, Biomedicine and PharmacotherapyCitation Excerpt :Therefore, the application of PEMFs might open up new perspectives for tendon regeneration Including the main applications mentioned above, PEMFs have also been shown to be beneficial in the treatment of lateral epicondylitis [152,153], fibromyalgia [154,155], degenerative disc disease [156–158], musculoskeletal chronic pain [21,159], and nerve regeneration [160,161]. As can be seen, the indications for PEMFs in the treatment of musculoskeletal disorders will continue to expand with time and experience.
Effects of electromagnetic fields on osteoarthritis
2019, Biomedicine and PharmacotherapyCitation Excerpt :The beneficial effects of PEMFs on the ECM are exerted through regulation of catabolic factors, such as MMP13. Inhibition of the MAPK signaling pathway might be involved in these effects [49]. It has been shown that various experimental parameters such as cell viability, ECM production, and cell cycle progression, result in different effects [46].